PACIFIC NORTHWEST RESEARCH FOU has a total of 23 patent applications. Its first patent ever was published in 1987. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are VERIDEX LLC, GENETYPE AG and CBSBIOSCIENCE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Unspecified technologies | |
#4 | Measuring light | |
#5 | Therapeutic chemical compounds | |
#6 | Medical preparations | |
#7 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Malins Donald C | 22 |
#2 | Holmes Eric H | 1 |
Publication | Filing date | Title |
---|---|---|
WO9900660A1 | Methods of differentiating metastatic and non-metastatic tumors | |
US5945675A | Methods of screening for a tumor or tumor progression to the metastatic state | |
AU6793996A | Methods for determining oxidative injury to DNA | |
CA2186704A1 | Methods for determining genotoxic states from nuclear dna phenotypes | |
EP0753146A1 | Methods for determining oxidative injury to dna | |
NZ266640A | Diagnosing genotoxic or carcinogenic status by analysing cellular redox potential where increased risk is indicated when the potential favours oxidatively derived modified nucleotides | |
AU3275493A | DNA biomarkers of cancer and genotoxic injury | |
US4971905A | Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase |